$3.36
0.041.2%
가까이에: Sep 24, 5:00 PM EST
$3.36
N/A
시간외: 4:26 PM EST
Benzinga
Benzinga
Benzinga
금요일, 9월 25
GoodRx Holdings Inc
GDRXNASDAQ
GoodRx Holdings Earnings & Forecasts
GoodRx Holdings (GDRX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
GoodRx Holdings Guidance
GoodRx Holdings (GDRX)는 8월 5, 2026에 fiscal year 2026에 대한 가이던스를 마지막으로 발표했습니다. 회사는 해당 기간의 매출을 $790M - $805M 범위로 예상했습니다.
이전 가이던스와 비교하여 GoodRx Holdings는 매출 전망치를 이전 범위인 상향 조정됨에서 $765M - $785M로 상향 조정했습니다.
GoodRx Holdings은 25과 11월 8, 2022 사이에 8월 5, 2026개의 지침 업데이트를 발표했습니다. During this period, the company raised its outlook 8 times and lowered it 10 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.07 | $0.06 | $0.07 | $0.07 |
| Actual | $0.08 | $0.07 | $0.09 | $0.08 |
| Surprise | +14.3% | +16.7% | +28.6% | +14.3% |
| Revenue | ||||
| Estimate | $193.1M | $184.1M | $192.8M | $194.1M |
| Actual | $200.4M | $194.0M | $194.8M | $196.0M |
| Surprise | +3.79% | +5.37% | +1.04% | +1.01% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.07 | $0.07 | $0.05 | $0.05 |
| Revenue | ||||
| Consensus | $202.6M | $201.9M | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved